Pharmaceuticals · Market research

Ovarian Cancer Therapeutics reports

Coverage across 33 countries and regions. Researched figures and forecasts come with the full report.

Get the full Ovarian Cancer Therapeutics market evidence

The purchased report supplies researched market size, forecast, growth, segments, competition and sources.

Buy the full report Request free sample
Ovarian Cancer Therapeutics reports by place
PlaceCurrent sizeForecastGrowthActive trialsReport
WorldIn full reportIn full reportIn full report1,338View report
AfricaIn full reportIn full reportIn full report22View report
APACIn full reportIn full reportIn full report380View report
AustraliaIn full reportIn full reportIn full report97View report
BrazilIn full reportIn full reportIn full report32View report
CanadaIn full reportIn full reportIn full report115View report
ChinaIn full reportIn full reportIn full report248View report
EcuadorIn full reportIn full reportIn full report0View report
EgyptIn full reportIn full reportIn full report19View report
EuropeIn full reportIn full reportIn full report331View report
FranceIn full reportIn full reportIn full report150View report
GermanyIn full reportIn full reportIn full report65View report
Hong KongIn full reportIn full reportIn full report10View report
IndiaIn full reportIn full reportIn full report13View report
ItalyIn full reportIn full reportIn full report139View report
JapanIn full reportIn full reportIn full report82View report
KenyaIn full reportIn full reportIn full report0View report
Latin AmericaIn full reportIn full reportIn full report38View report
MalaysiaIn full reportIn full reportIn full report3View report
MexicoIn full reportIn full reportIn full report17View report
Middle EastIn full reportIn full reportIn full report7View report
New ZealandIn full reportIn full reportIn full report7View report
North AmericaIn full reportIn full reportIn full report629View report
PhilippinesIn full reportIn full reportIn full report2View report
RussiaIn full reportIn full reportIn full report13View report
Saudi ArabiaIn full reportIn full reportIn full report3View report
SingaporeIn full reportIn full reportIn full report14View report
South AfricaIn full reportIn full reportIn full report1View report
SpainIn full reportIn full reportIn full report124View report
ThailandIn full reportIn full reportIn full report9View report
UAEIn full reportIn full reportIn full report0View report
UKIn full reportIn full reportIn full report103View report
USIn full reportIn full reportIn full report594View report

Public clinical research

1,338 active trials found worldwide on ClinicalTrials.gov.

See the public search

Latest public research

  1. Epigenetic Divergence Distinguishes Molecularly and Histologically Distinct Subtypes of Small Cell Carcinoma of the Ovary Hypercalcemic Type.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2026
  2. Racial and ethnic differences in ovarian cancer survival across SEER registry states.Gynecologic oncology, 2026
  3. The p38α MAPK-MK2 axis drives chemotherapy-mediated nuclear actin remodeling to promote ovarian cancer progression.Proceedings of the National Academy of Sciences of the United States of America, 2026
  4. Cell-death-associated inflammatory remodeling of the SPP1/KRT5 axis in high-grade serous ovarian cancer: multi-omics, single-cell, and irradiation validation.Frontiers in cell and developmental biology, 2026
  5. Fertility-sparing surgery for early-stage epithelial ovarian cancer: evolving criteria for patient selection.Japanese journal of clinical oncology, 2026

Top Ovarian Cancer Therapeutics companies and key players

Public trial and paper counts come from ClinicalTrials.gov and PubMed. Acuitas market figures are not published on this page.